BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29783317)

  • 21. Research Highlights: Highlights from the latest articles in molecular profiling and prognosis in acute myeloid leukemia.
    Aljitawi OS; Lin TL
    Per Med; 2012 Sep; 9(7):679-682. PubMed ID: 29776265
    [No Abstract]   [Full Text] [Related]  

  • 22. Research Highlights: highlights from the latest articles focusing on a new gene set for better drug response prediction of epilepsy patients.
    Baghel R; Jajodia A; Grover S; Kukreti R
    Pharmacogenomics; 2014 Apr; 15(5):581-6. PubMed ID: 24798714
    [No Abstract]   [Full Text] [Related]  

  • 23. Knowledge and attitudes concerning pharmacogenomics among healthcare professionals.
    Dodson C
    Per Med; 2011 Jul; 8(4):421-428. PubMed ID: 29783331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research highlights from the latest articles in diabetes research.
    Reitman ML
    Per Med; 2010 May; 7(3):245-248. PubMed ID: 29776216
    [No Abstract]   [Full Text] [Related]  

  • 25. Highlights from the latest articles in suicide research.
    Antypa N; Serretti A
    Per Med; 2014 May; 11(3):255-258. PubMed ID: 29764061
    [No Abstract]   [Full Text] [Related]  

  • 26. Cambridge Healthtech Institute's 2nd Annual Conference on Pharmacogenomics Europe: presaging profits.
    Kerb R; Brinkmann U
    Pharmacogenomics; 2001 Aug; 2(3):303-5. PubMed ID: 11939136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics and public health: implementing 'populationalized' medicine.
    Mette L; Mitropoulos K; Vozikis A; Patrinos GP
    Pharmacogenomics; 2012 May; 13(7):803-13. PubMed ID: 22594512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Génome Québec & Montreal Heart Institute Pharmacogenomics Centre: a translational pharmacogenomics platform--from R&D to the clinic.
    Phillips MS; Hihi AK; van Rooij T; Smith AC; James S; Marsh S; Laplante N; Dubé MP; Tardif JC
    Pharmacogenomics; 2008 Oct; 9(10):1391-6. PubMed ID: 18855527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis.
    Blaya C; Salum GA; Lima MS; Leistner-Segal S; Manfro GG
    Behav Brain Funct; 2007 Aug; 3():41. PubMed ID: 17705872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latest trends in preventive medicine: highlights of the PreMed 2008 meeting, 6 - 7 June 2008, Monza, Italy.
    Pandiani L; Souêtre A
    Expert Opin Med Diagn; 2009 Mar; 3(2):207-10. PubMed ID: 23485166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socioethical responsibilities.
    Egalité N; Ozdemir V; Godard B
    Pharmacogenomics; 2007 Sep; 8(9):1115-26. PubMed ID: 17924827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HTTLPR genotype and associations with intoxication and intention to drive: results from a field study of bar patrons.
    Thombs DL; O'Mara RJ; Hou W; Wagenaar AC; Dong HJ; Merves ML; Goldberger BA; Weiler RM; Dodd VJ; Clapp JD
    Addict Biol; 2011 Jan; 16(1):133-41. PubMed ID: 20579008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
    Kowalec K; Carleton B; Tremlett H
    Mult Scler Relat Disord; 2013 Jul; 2(3):183-92. PubMed ID: 25877724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics of episodic migraine: time has come for a step forward.
    Viana M; Terrazzino S; Genazzani AA; Grieco GS; Cargnin S; Santorelli FM; Pierelli F; Tassorelli C; Nappi G; Di Lorenzo C
    Pharmacogenomics; 2014 Mar; 15(4):541-9. PubMed ID: 24624920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highlights from the latest articles in lung cancer personalized medicine.
    Rivas-Perez H; Carbone DP; Nana-Sinkam SP
    Per Med; 2014 Jun; 11(4):377-379. PubMed ID: 29783480
    [No Abstract]   [Full Text] [Related]  

  • 36. Highlights from the latest articles in personalized medicine.
    O'Connell TM
    Per Med; 2014 Jan; 11(1):11-13. PubMed ID: 29751392
    [No Abstract]   [Full Text] [Related]  

  • 37. Highlights from the latest articles in nanomaterial-based therapies for targeting cancer stem cells.
    Yoshii T; Geng Y; Le ND; Goel HL; Mercurio AM; Rotello VM
    Nanomedicine (Lond); 2015; 10(23):3427-9. PubMed ID: 26606862
    [No Abstract]   [Full Text] [Related]  

  • 38. Highlights from the latest articles in nanomedicine: light-activated therapeutics.
    Miranda D; Lovell JF
    Nanomedicine (Lond); 2015 Nov; 10(22):3321-3. PubMed ID: 26582276
    [No Abstract]   [Full Text] [Related]  

  • 39. Highlights from the latest articles in nanomedicine for reproductive oncology.
    Jones C; Barkalina N; Coward K
    Nanomedicine (Lond); 2015 May; 10(9):1375-7. PubMed ID: 25996116
    [No Abstract]   [Full Text] [Related]  

  • 40. Highlights from the latest articles in technical and technological advancements in nanotherapeutics.
    Tay CY; Leong DT
    Nanomedicine (Lond); 2015; 10(7):1047-9. PubMed ID: 25929563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.